FDA approves Bristol Myers Squibb’s schizophrenia drug, the first new type of treatment in decades

by | Sep 26, 2024 | Consumer Products, FEATURED, HEADLINE, Investing, Stocks

The Food and Drug Administration on Thursday approved Bristol Myers Squibb’s highly anticipated schizophrenia drug, the first novel type of treatment …

FEATURED